NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...
The stock's fall snapped a two-day winning streak.
AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback